MHRA study to look at whether AI could predict drug interactions
By Liz Wells 22 October 2025
A new study will use AI and NHS data to predict side effects from drug combinations before they reach patients.
Targeted breast cancer treatment approved for routine NHS use
By Liz Wells 11 April 2025
NICE is recommending capivasertib with fulvestrant to treat women with advanced breast cancer, which means the drug will be funded immediately through the Cancer Drugs Fund.
NHS offers 'new hope' for children with severe epilepsy
By Liz Wells 20 February 2025
Hundreds of children with severe epilepsy will be able to benefit from a groundbreaking new treatment on the NHS that could significantly reduce their seizures.
Assistant Director – Public Health (Partnerships & Commissioning)
£98,673 - £111,60
Leicestershire£98,673 - £111,60
Most Read News
Assistant Director – Public Health (Partnerships & Commissioning)
£98,673 - £111,60
Leicestershire£98,673 - £111,60
Most Read News
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
